top of page
  • Writer's pictureAdastra

Historic Bull Market Valuations

Updated: Nov 13, 2023

"Those that fail to learn from history, are doomed to repeat it."

- Winston Churchill

This page presents an analysis of historical bull market valuations of prominent cannabis stocks using PS Ratios from 2017 to 2022. A huge thank you to for allowing me to use their PS Ratio data.

The timeline for this analysis is January 2017 to January 2022. The table shows relative valuations (using PS ratio) during the cannabis sector bull markets of 2018 (during Canada’s legalization of cannabis) and 2021 (when the Democrats came into power promising Cannabis decriminalization and progress on legalization). A detailed narrative on these numbers is presented in the post Cannabis Investing 4: Gladiators, Senators, the Colosseum and the Senate.

The data has many data points that would make a Vulcan (or Human) raise an eyebrow.

It is fascinating to see the Senate (Nasdaq/NYSE) listed Licensed Producers having multiple instances with triple digit (100+ PS Ratios). Per YCharts, Tilray had almost 1000 PS during the 2018 bull market driven by Canada's legalization of cannabis. The OTC (Colosseum) listed companies also had impressive PS ratios during the bull markets, but were valued at a lot lower multiples.

The following are the screenshots from YCharts used for this analysis. This is a historical analysis and these charts are from January 2022. You can visit and search stock tickers to find current charts.

FABCBD Sleep Gummies for nighttime use which has CBD along with natural ingredients like Ashwagandha, a herb used in Ayurveda, the ancient plant medicine of India

Nasdaq listed “Senators”

Tilray 2017-Jan to 2022-Jan PS:

Tilray 2021 PS:

Canopy Growth 2017-Jan to 2022-Jan PS:

Canopy Growth 2021 PS:

Aurora Cannabis 2017-Jan to 2022-Jan PS:

Aurora Cannabis 2021 PS:

For those like me who like consuming in the format of oils, FABCBD has CBD oils in different flavors and strengths

SNDL (formerly Sundial Growers) 2017-Jan to 2022-Jan PS:

SNDL 2021 PS:

Cronos Group 2017-Jan to 2022-Jan PS:

Cronos Group 2021 PS:

HEXO Corp 2017-Jan to 2022-Jan PS:

HEXO Corp 2021 PS:

FABCBD has CBD dog treats

OTC listed “Gladiators”

Curaleaf Holdings 2017-Jan to 2022-Jan PS:

Curaleaf Holdings 2021 PS:

Green Thumb Industries 2017-Jan to 2022-Jan PS:

Green Thumb Industries 2021 PS:

Trulieve Cannabis 2017-Jan to 2022-Jan PS:

Trulieve Cannabis 2021 PS:

Cresco Labs 2017-Jan to 2022-Jan PS:

Cresco Labs 2021 PS:

High Tide 2017-Jan to 2022-Jan PS:

Note: High Tide uplisted from OTC to Nasdaq in June 2021 and was on OTC through 2018 and 2021 Bull markets.

High Tide 2021 PS:

Verano Holdings 2017-Jan to 2022-Jan PS:

Note: Verano started trading on CSE/OTC in Feb 2021.

If you find any article here worth sharing, please share via the social media share options. If you are interested in connecting, you can do so on Twitter (@numbersnarrati) and Stocktwits (@AdastraYOLO). To support, please check out the affiliate links (especially CBD and other cannabinoid products) or become a Patron via the Numbers Narrative Patreon Page.

Disclaimer: All content and analysis on this Blog/website is information shared for educational and entertainment purposes only. The content creator(s) of this Blog are not financial advisors and the content is not intended to provide advice or recommendations for any security, investment product or any other product or service mentioned on this Blog. You should not use this Blog to make financial decisions and you should instead seek advice from professionals who are authorized to provide investment advice. Although best efforts have been taken to keep the information on this Blog accurate, this Blog may contain errors and inaccuracies. You alone assume the sole responsibility of the risks associated with the use of any content on the Blog. In no event shall any of the content creators be liable for any damages in connection with the information contained in this Blog or links provided.

Disclosure: I (username Adastra) am an investor not a trader. I am bullish on the Cannabis sector as a long-term investment (2026 and beyond), provided stocks/ETFs are carefully picked based on data-driven due diligence. Of the 16 stocks covered in the Best Cannabis Stocks analysis, I have invested only in my top 3 picks: High Tide, Green Thumb and Curaleaf. But my analysis indicates (without any guarantees) that there is a potential for impressive gains in investing in the stocks best ranked in the analysis, including WM Technology, and Trulieve, which have a dedicated page with detailed analysis in the STOCKS category. I reserve the right to buy or sell at any time any of the stocks mentioned in this blog. I do not short stocks and never will short any stock in a company that makes the world a better place. I do not have insider knowledge of any company covered in this blog. All data used for analysis is from public sources. I have received (as of last update date of this page) ZERO funding for this blog from any of the companies featured in this blog.


bottom of page